Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Chinese Patent Office
QuintilesIMS
Fuji
Colorcon

Generated: July 16, 2019

DrugPatentWatch Database Preview

Patent: 9,248,115

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,248,115
Title:Silibinin component for the treatment of hepatitis
Abstract: The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin.
Inventor(s): Rovati; Lucio Claudio (Monza, IT), D\'Amato; Massimo Maria (Monza, IT), Mengs; Ulrich (Roesrath, DE), Pohl; Ralf-Torsten (Speyer, DE), Ferenci; Peter (Vienna, AU)
Assignee: MADAUS GMBH (Cologne, DE)
Application Number:13/871,045
Patent Claims:see list of patent claims

Details for Patent 9,248,115

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14 ➤ Try a Free Trial MADAUS GMBH (Cologne, DE) ➤ Try a Free Trial RX search
Hoffman-la Roche PEGASYS peginterferon alfa-2a SYRINGE 103964 002 2002-10-16 ➤ Try a Free Trial MADAUS GMBH (Cologne, DE) ➤ Try a Free Trial RX search
Hoffman-la Roche PEGASYS peginterferon alfa-2a VIAL; SUBCUTANEOUS 103964 001 2002-10-16 ➤ Try a Free Trial MADAUS GMBH (Cologne, DE) ➤ Try a Free Trial RX search
Schering SYLATRON peginterferon alfa-2b VIAL 103949 011 2001-01-19 ➤ Try a Free Trial MADAUS GMBH (Cologne, DE) ➤ Try a Free Trial RX Orphan search
Schering SYLATRON peginterferon alfa-2b VIAL 103949 010 2001-01-19 ➤ Try a Free Trial MADAUS GMBH (Cologne, DE) ➤ Try a Free Trial RX Orphan search
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19 ➤ Try a Free Trial MADAUS GMBH (Cologne, DE) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
McKesson
Mallinckrodt
Fuji
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.